FISH in an expanded cohort of 28 primary AS, 31 radiation-associated AS, and 2 lymphedema-associated AS cases detected MYC amplification in 55% of secondary AS, but not in primary AS; indicating MYC amplification is exclusive to secondary AS, and detectable irrespective of aetiology. This evidence concerns the gene MYC and lymphedema.